Financhill
Sell
27

MBAI.CX Quote, Financials, Valuation and Earnings

Last price:
$0.08
Seasonality move :
32.62%
Day range:
$0.08 - $0.08
52-week range:
$0.02 - $0.13
Dividend yield:
0%
P/E ratio:
7.62x
P/S ratio:
5.78x
P/B ratio:
3.47x
Volume:
--
Avg. volume:
60.7K
1-year change:
300%
Market cap:
$9M
Revenue:
$1.2M
EPS (TTM):
$0.01

Earnings Data

Next earnings date for MBAI.CX
--
Most recent earnings per share
$0.00
Beat by $0.00
(Aug 31/2025)
Consensus Estimate
--
(Aug 31/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MBAI.CX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/31/2025 Q3 -- $114K $0.00 -- --
05/31/2025 Q2 -- $272.4K -$0.00 -- --
02/28/2025 Q1 -- $1.1M $0.05 -- --
11/30/2024 Q4 -- $28.7K -$0.04 -- --
08/31/2024 Q3 -- -- -- -- --
05/31/2024 Q2 -- -- -$0.00 -- --
02/29/2024 Q1 -- -- $0.00 -- --
11/30/2023 Q4 -- -- -$0.01 -- --
08/31/2023 Q3 -- -- -$0.15 -- --
05/31/2023 Q2 -- -- -$0.02 -- --
02/28/2023 Q1 -- -- $0.00 -- --
11/30/2022 Q4 -- -- -$0.05 -- --
08/31/2022 Q3 -- -- -$0.01 -- --
05/31/2022 Q2 -- -- -$0.01 -- --
02/28/2022 Q1 -- -- -$0.01 -- --
11/30/2021 Q4 -- -- -$0.05 -- --
08/31/2021 Q3 -- -- $0.02 -- --
05/31/2021 Q2 -- -- -$0.01 -- --
02/28/2021 Q1 -- -- -$0.04 -- --
11/30/2020 Q4 -- -- -$0.00 -- --
08/31/2020 Q3 -- -- -$0.00 -- --
05/31/2020 Q2 -- -- -$0.00 -- --
02/29/2020 Q1 -- -- -$0.29 -- --
11/30/2019 Q4 -- -- -$0.00 -- --
08/31/2019 Q3 -- -- -$0.00 -- --
05/31/2019 Q2 -- -- -$0.00 -- --
02/28/2019 Q1 -- -- -$0.14 -- --
11/30/2018 Q4 -- -- -$0.00 -- --
08/31/2018 Q3 -- -- -$0.01 -- --
05/31/2018 Q2 -- -- -$0.00 -- --
02/28/2018 Q1 -- -- -$0.03 -- --
11/30/2017 Q4 -- -- -$0.00 -- --
08/31/2017 Q3 -- -- -$0.01 -- --
05/31/2017 Q2 -- -- -$0.00 -- --
02/28/2017 Q1 -- -- -$0.03 -- --
11/30/2016 Q4 -- -- -$0.00 -- --
08/31/2016 Q3 -- -- -$0.00 -- --
05/31/2016 Q2 -- -- -$0.00 -- --
02/29/2016 Q1 -- -- -$0.00 -- --

MedBright AI Investments, Inc. Earnings Questions

  • How Much did MedBright AI Investments, Inc. Generate in Revenue Last Quarter?

    MedBright AI Investments, Inc. reported $114K worth of top line sales in its most recent quarter.

  • Did MedBright AI Investments, Inc. Beat Earnings Last Quarter?

    MedBright AI Investments, Inc. announced earnings per share of $0.00 which represents a beat of analyst forecast a -- per share.

  • Is MedBright AI Investments, Inc. Profitable?

    MedBright AI Investments, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for MedBright AI Investments, Inc. EPS Next Year?

    MedBright AI Investments, Inc.'s earnings are forecast to grow from $0.01 per share to -- per share next year representing an increase of --.

  • When is MedBright AI Investments, Inc.'s Earnings Date?

    Currently, MedBright AI Investments, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 23, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 22

Lamb Weston Holdings, Inc. [LW] is down 2.59% over the past day.

Buy
54
BMRN alert for Dec 22

BioMarin Pharmaceutical, Inc. [BMRN] is down 3.03% over the past day.

Buy
82
RKLB alert for Dec 22

Rocket Lab Corp. [RKLB] is up 9.97% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock